{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:29:38Z","timestamp":1761647378407},"reference-count":38,"publisher":"Informa UK Limited","issue":"sup2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1586\/14737175.4.6.s27","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T10:52:08Z","timestamp":1131619928000},"page":"S27-S33","source":"Crossref","is-referenced-by-count":8,"title":["Bipolar depression: the role of atypical antipsychotics"],"prefix":"10.1586","volume":"4","author":[{"given":"Robert M","family":"Post","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Judd LL, Akiskal HS, Schettler PJet al.The long-term natural history of the weekly symptomatic status of bipolar I disorder.Arch. Genet. Psychiatry59, 530\u2013537 (2002).","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Post RM, Denicoff KD, Leverich GSet al.Morbidity in 258 bipolar out-patients followed for 1 year with daily prospective ratings on the NIMH life chart method.J. Clin. Psychiatry64, 680\u2013690 (2003).","DOI":"10.4088\/JCP.v64n0610"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Judd LL, Akiskal HS, Schettler PJet al.A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.Arch. Genet. Psychiatry60, 261\u2013269 (2003).","DOI":"10.1001\/archpsyc.60.3.261"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention.CNS Drugs17, 491\u2013511 (2003).","DOI":"10.2165\/00023210-200317070-00003"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Perugi G, Micheli C, Akiskal HSet al.Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients.Compr. Psychiatry41, 13\u201318 (2000).","DOI":"10.1016\/S0010-440X(00)90125-1"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Keller MB, Lavori PW, Coryell Wet al.Differential outcome in pure manic, mixed\/cycling, and pure depressive episodes in patients with bipolar illness.JAMA255, 3138\u20133142 (1986).","DOI":"10.1001\/jama.255.22.3138"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research.J. Clin. Psychopharmacol.13, 397\u2013408 (1993).","DOI":"10.1097\/00004714-199312000-00005"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Calabrese JR, Bowden CL, Sachs Get al.A placebo-controlled 18-month study of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar disorder.J. Clin. Psychiatry 64, 1013\u20131024 (2003).","DOI":"10.4088\/JCP.v64n0906"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"Bowden CL, Calabrese JR, Sachs Get al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.Arch. Genet. Psychiatry60, 392\u2013400 (2003).","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Calabrese JR, Bowden CL, Sachs GSet al.A double-blind placebo-controlled study of lamotrigine monotherapy in out-patients with bipolar I depression. Lamictal 602 Study Group.J. Clin. Psychiatry60, 79\u201388 (1999).","DOI":"10.4088\/JCP.v60n0203"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Parker G, Parker K. Which antidepressants flick the switch?Aust. NZ J. Psychiatry37, 464\u2013468 (2003).","DOI":"10.1046\/j.1440-1614.2003.01207.x"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies.Bipolar Disord.5, 407\u2013420 (2003).","DOI":"10.1046\/j.1399-5618.2003.00067.x"},{"key":"CIT0013","unstructured":"American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision).Am. J. Psychiatry159(Suppl. 4), 1\u201350 (2002)."},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.J. Psychopharmacol.17, 149\u2013173 (2003).","DOI":"10.1177\/0269881103017002003"},{"key":"CIT0015","unstructured":"Keck PE Jr, McElroy SL. New approaches in managing bipolar depression.J. Clin. Psychiatry64(Suppl. 1), 13\u201318 (2003)."},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Kasper S. Treatment of depressive symptoms with quetiapine. Expert Rev. Neurotherapeutics 3, 89\u201395 (2003).","DOI":"10.1586\/14737175.3.4.417"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Kasper S, Stamenkovic M, Letmaier M, Schreinzer D. Atypical antipsychotics in mood disorders.Int. Clin. Psychopharmacol.17(Suppl. 3), S1\u2013S10 (2002).","DOI":"10.1097\/00004850-200206001-00001"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Lahti RA, Tamminga CA. Effect of amphetamine, alpha-methyl-p-tyrosine and antipsychotic agents on dopamine D2-type receptor occupancy in rats.Prog. Neuropsychopharmacol. Biol. Psychiatry23, 1277\u20131283 (1999).","DOI":"10.1016\/S0278-5846(99)00064-0"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Schotte A, Janssen PF, Gommeren Wet al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.Psychopharmacology124, 57\u201373 (1996).","DOI":"10.1007\/BF02245606"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence.Neuropsychopharmacology18, 63\u2013101 (1998).","DOI":"10.1016\/S0893-133X(97)00112-7"},{"key":"CIT0021","doi-asserted-by":"crossref","unstructured":"Kapur S, Mamo D. Half a century of antipsychotics and still a central role for dopamine D2 receptors.Prog. Neuropsychopharmacol. Biol. Psychiatry27, 1081\u20131090 (2003).","DOI":"10.1016\/j.pnpbp.2003.09.004"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Richelson E. Synaptic effects of antidepressants.J. Clin. Psychopharmacol.16(3 Suppl. 2), 1S\u20137S (1996).","DOI":"10.1097\/00004714-199606002-00001"},{"key":"CIT0023","doi-asserted-by":"crossref","unstructured":"Saller CF, Salama AI. Seroquel: biochemical profile of a potential atypical antipsychotic.Psychopharmaology (Berl)112, 285\u2013292 (1993).","DOI":"10.1007\/BF02244923"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Tohen M, Vieta E, Calabrese Jet al. Efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression.Arch. Genet. Psychiatry60, 1079\u20131088 (2003).","DOI":"10.1001\/archpsyc.60.11.1079"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Vieta E, Goikolea JM, Corbella Bet al. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.J. Clin. Psychiatry62, 818\u2013825 (2001).","DOI":"10.4088\/JCP.v62n1011"},{"key":"CIT0026","unstructured":"Calabrese J, Macfadden W, McCoy R, Minkwitz M, Wilson E, Mullen J. Double-blind, placebo-controlled study of quetiapine in bipolar depression.157th Annual Meeting of the American Psychiatric Association, NY, USA. 1\u20136th May (2004)."},{"key":"CIT0027","unstructured":"Baldassano CF, Paulsson B, Brecher M. Quetiapine treatment of depressive symptoms in bipolar mania.157th Annual Meeting of the American Psychiatric Association, 1\u20136th May, NY, USA (2004) (Abstract NR736)."},{"key":"CIT0028","doi-asserted-by":"crossref","unstructured":"DelBello MP, Schwiers ML, Rosenberg HL, Stratowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am.Acad. Child. Adolesc. Psychiatry41, 1216\u20131223 (2002).","DOI":"10.1097\/00004583-200210000-00011"},{"key":"CIT0029","unstructured":"Ghaemi SN, Goldberg JF, Henry CA et al. Quetiapine for rapid-cycling bipolar disorder: a long-term follow-up study.Bipolar Disord.5(Suppl. 1), 50 (2003) (Abstract p73)."},{"key":"CIT0030","doi-asserted-by":"crossref","unstructured":"Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in patients with bipolar disorder and cocaine dependence.Bipolar Disord.4, 406\u2013411 (2002).","DOI":"10.1034\/j.1399-5618.2002.02229.x"},{"key":"CIT0031","doi-asserted-by":"crossref","unstructured":"Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in out-patients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.Clin. Ther.23, 1839\u20131854 (2001).","DOI":"10.1016\/S0149-2918(00)89080-3"},{"key":"CIT0032","unstructured":"Purdon SE, Malla A, Labelle A, Lit W. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.J. Psychiatry Neurosci.26, 137\u2013149 (2001)."},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"Sajatovic M, Mullen JA, Sweitzer DE. Efficacy of quetiapine and risperidone against depressive symptoms in out-patients with psychosis.J. Clin. Psychiatry63, 1156\u20131163 (2002).","DOI":"10.4088\/JCP.v63n1211"},{"key":"CIT0034","doi-asserted-by":"crossref","unstructured":"Zarate CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders.J. Clin. Psychiatry61, 185\u2013189 (2000).","DOI":"10.4088\/JCP.v61n0307"},{"key":"CIT0035","unstructured":"Keck PE Jr. New anti-epileptics in the treatment of bipolar disorder. Poster presented at the 154th Annual Meeting of the American Psychiatric Association, May 5\u201310, New Orleans, LA, USA (2001) (Abstract 34E)."},{"key":"CIT0036","doi-asserted-by":"crossref","unstructured":"Post RM, Leverich GS, Altshuler LL et al. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).Bipolar Disord.5, 310\u2013319 (2003).","DOI":"10.1034\/j.1399-5618.2003.00051.x"},{"key":"CIT0037","doi-asserted-by":"crossref","unstructured":"Suppes T, McElroy S, Keck Pet al. Use of quetiapine in bipolar disorder: a case series with prospective evaluation.Int. Clin. Psychopharmacol.19, 173\u2013174 (2004).","DOI":"10.1097\/00004850-200405000-00010"},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"Becker D, Liver O, Mester Ret al. Risperidone, but not olanzapine, decreases bone mineral density in female pre-menopausal schizophrenia patients.J. Clin. Psychiatry64, 761\u2013766 (2003).","DOI":"10.4088\/JCP.v64n0704"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737175.4.6.S27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T19:43:48Z","timestamp":1586547828000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737175.4.6.S27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":38,"journal-issue":{"issue":"sup2","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1586\/14737175.4.6.S27"],"URL":"https:\/\/doi.org\/10.1586\/14737175.4.6.s27","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}